Albemarle's Q2 revenue beats estimates on higher lithium pricing
ALB•What drove the improvement
- Energy Storage pricing - Higher lithium pricing drove a 78% increase in Energy Storage net sales.
- Specialties volume and pricing - Higher volumes (+8%) and pricing (+11%) in Specialties, especially in bromine and derivatives, contributed to segment growth.
- Cost and productivity improvements - Ongoing cost and productivity improvements supported higher adjusted EBITDA.
Outlook and analyst coverage
Albemarle said it sees FY 2026 net sales between $4.1 bln and $7.8 bln depending on lithium prices. The company expects FY 2026 capital expenditures of about $500 mln, down 15% from 2025.
It also raised its FY 2026 Specialties net sales outlook to $1.4-$1.6 bln and EBITDA to $275-$325 mln.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell". The average consensus recommendation for the specialty chemicals peer group is "buy".
Wall Street's median 12-month price target for Albemarle Corp is $190.50, about 57.7% above its August 4 closing price of $120.82. The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 22 three months ago.
Quarterly results beat expectations
Albemarle's Q2 net sales rose 31%, beating analyst expectations, as higher lithium pricing lifted results. Q2 adjusted EBITDA also beat analyst expectations, driven by higher pricing and productivity gains.
